These findings, combined with results shown in Fig. 4C and D, suggested that transcriptional upregulation of SLC7A11 is not sufficient to prevent ferroptosis in sorafenib-treated HCC cells. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.